AVELUMAB
avelumab 200 mg/10 mL injection, 10 mL vial
AVELUMAB (11695M)
11695M
Manner of administration:Injection
Restriction 16053
Indication: Stage IV (metastatic) Merkel Cell Carcinoma
Treatment phase: Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 1200 mg | # of repeats: 8 | DPMA: $7,828.17 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
